June 18, 2025 a 01:00 pm
DGX: Fundamental Ratio Analysis - Quest Diagnostics Incorporated
Quest Diagnostics Incorporated, with its wide range of diagnostic information services, has a moderate growth potential given its comprehensive diagnostic solutions and extensive network. While its fundamental scores indicate a mix of strengths and weaknesses, the firm's consistent innovation in the healthcare diagnostics sector positions it well for future advancements.
Fundamental Rating
Quest Diagnostics presents a moderate to good overall fundamental rating with strengths in return metrics, though it shows weakness in debt levels and valuation multiples.
| Category | Score / 5 | Score Bar |
|---|---|---|
| Discounted Cash Flow (DCF) | 4 | |
| Return on Equity (ROE) | 4 | |
| Return on Assets (ROA) | 5 | |
| Debt to Equity | 1 | |
| Price to Earnings | 2 | |
| Price to Book | 2 |
Historical Rating
The historical rating showcases consistency in certain aspects but indicates variability in overall performance.
| Date | Overall | DCF | ROE | ROA | Debt to Equity | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2025-06-18 | 3 | 4 | 4 | 5 | 1 | 2 | 2 |
| 2025-06-17 | 3 | 4 | 4 | 5 | 1 | 2 | 2 |
Analyst Price Targets
Analysts have set conservative targets reflecting the market's cautious outlook, with a consensus holding steady at a mid-range level.
| High | Low | Median | Consensus |
|---|---|---|---|
| $195 | $180 | $185.5 | $186.5 |
Analyst Sentiment
Current analyst sentiment suggests a prevailing neutral stance, with a majority recommending to hold positions.
| Recommendation | Number of Analysts | Distribution |
|---|---|---|
| Strong Buy | 0 | |
| Buy | 14 | |
| Hold | 17 | |
| Sell | 3 | |
| Strong Sell | 0 |
Conclusion
Quest Diagnostics Incorporated showcases moderate strength in returns and robust innovation, but faces challenges in its debt management and valuation metrics. The stock's analyst sentiment is predominantly neutral, suggesting a cautious approach from the market. While the price goals indicate some potential upside, the risks associated with high debt levels warrant careful consideration. In conclusion, DGX represents a balanced mix of opportunities and challenges, reflective of its stable yet competitive standing in the healthcare diagnostics industry.